U.S. Markets closed
  • S&P Futures

    3,855.50
    +10.50 (+0.27%)
     
  • Dow Futures

    31,142.00
    +46.00 (+0.15%)
     
  • Nasdaq Futures

    13,370.50
    +76.25 (+0.57%)
     
  • Russell 2000 Futures

    2,158.00
    +0.30 (+0.01%)
     
  • Crude Oil

    53.28
    +0.04 (+0.08%)
     
  • Gold

    1,872.50
    +6.00 (+0.32%)
     
  • Silver

    26.00
    +0.24 (+0.93%)
     
  • EUR/USD

    1.2133
    +0.0018 (+0.1456%)
     
  • 10-Yr Bond

    1.0900
    -0.0020 (-0.18%)
     
  • Vix

    21.58
    -1.66 (-7.14%)
     
  • GBP/USD

    1.3684
    +0.0029 (+0.2135%)
     
  • USD/JPY

    103.5340
    -0.0360 (-0.0348%)
     
  • BTC-USD

    34,674.73
    +12.12 (+0.03%)
     
  • CMC Crypto 200

    688.26
    -12.35 (-1.76%)
     
  • FTSE 100

    6,740.39
    +27.44 (+0.41%)
     
  • Nikkei 225

    28,727.48
    +204.22 (+0.72%)
     

Critical Elements Announces Second Closing of $165,000

MONTREAL, QUEBEC--(Marketwired - Dec 22, 2014) - Critical Elements Corporation (TSX VENTURE:CRE)(CRECF) (F12.F) is pleased to announce that it has closed the second tranche of a non-brokered private placement, for an amount of $165,000.

The Company has issued 660,000 units of common shares at a price of $0.25 per share for gross proceeds of $165,000. Each unit consists of one common share priced at $0.25 and one half of one purchase warrant. Each whole purchase warrant entitles the holder thereof to purchase one common share of the Corporation for a period of 36 months at a price of $0.35 per share.

The Company paid Mackie Research Capital intermediary fees of $5,200, along with 20,800 compensation options entitling their holders to purchase 20,800 common shares of the Company at a price of $0.35 per share for a 36-month period following the closing of the private placement.

All the securities issued under the private placement are subject to a mandatory hold period of four months plus one day following the closing of the private placement.

The proceeds of this private placement will be used for working capital.

The private placement is subject to regulatory approval.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.